Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 31 AL 45

Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease

Cummings J, Scheltens P, McKeith I, Blesa R, Harrison JE, Bertolucci PH, Rockwood K, Wilkinson D, Wijker W, Bennett DA, Shah RC.

J Alzheimers Dis. 2017;55(3):1131-1139. doi: 10.3233/JAD-160745.

Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease

de la Rubia Ortí JE, Sancho Castillo S, Benlloch M, Julián Rochina M, Corchón Arreche S, García-Pardo MP.

J Alzheimers Dis. 2017;55(3):899-903. doi: 10.3233/JAD-160903.

Copy Number Variants in Alzheimer's Disease

Cuccaro D, De Marco EV, Cittadella R, Cavallaro S.

J Alzheimers Dis. 2017;55(1):37-52. doi: 10.3233/JAD-160469.

Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease

Tong Z, Wang W, Luo W, Lv J, Li H, Luo H, Jia J, He R.

J Alzheimers Dis. 2017;55(3):1031-1038. doi: 10.3233/JAD-160357.

Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review

D'Onofrio G, Sancarlo D, Ruan Q, Yu Z, Panza F, Daniele A, Greco A, Seripa D.

Curr Drug Targets. 2017;18(13):1487-1498. doi: 10.2174/1389450117666161102121553.

Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology

Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Ellingson SR, Morris JC, Goate AM, Kukull WA.

Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):232-238. doi: 10.1097/WAD.0000000000000179.

Sex and the development of Alzheimer's disease

Pike CJ.

J Neurosci Res. 2017 Jan 2;95(1-2):671-680. doi: 10.1002/jnr.23827.

Effects of altered RTN3 expression on BACE1 activity and Alzheimer's neuritic plaques

Sharoar MG, Yan R.

Rev Neurosci. 2017 Feb 1;28(2):145-154. doi: 10.1515/revneuro-2016-0054.

Protective Effects of Caffeic Acid and the Alzheimer's Brain: An Update

Habtemariam S.

Mini Rev Med Chem. 2017;17(8):667-674. doi: 10.2174/1389557516666161130100947.

Research update on Alzheimer's disease and introduction to the Expert Review of Neurotherapeutics special issue

Gauthier S.

Expert Rev Neurother. 2017 Jan;17(1):1-2. doi: 10.1080/14737175.2017.1268054.

Serotonin 5-HT(6) Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status

Ferrero H, Solas M, Francis PT, Ramirez MJ.

CNS Drugs. 2017 Jan;31(1):19-32. doi: 10.1007/s40263-016-0399-3.

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

Venkataraman A, Kalk N, Sewell G, Ritchie CW, Lingford-Hughes A.

Alcohol Alcohol. 2017 Mar 9;52(2):151-158. doi: 10.1093/alcalc/agw092.

Direct infusion mass spectrometry for metabolomic phenotyping of diseases

González-Domínguez R, Sayago A, Fernández-Recamales Á.

Bioanalysis. 2017 Jan;9(1):131-148. doi: 10.4155/bio-2016-0202.

Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

Liao F, Yoon H, Kim J.

Curr Opin Lipidol. 2017 Feb;28(1):60-67. doi: 10.1097/MOL.0000000000000383.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias